Skip to content

Cranberry extracts for urinary tract infections

Profiling Vaccinium macrocarpon components and metabolites in human urine and the urine ex-vivo effect on Candida albicans adhesion and biofilm-formation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN32556347
Enrollment
10
Registered
2019-09-05
Start date
2019-01-15
Completion date
Unknown
Last updated
2023-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary tract infection Urological and Genital Diseases Urinary tract infection

Interventions

Ten healthy women will be enrolled and randomized for the intervention. Subjects will be randomized, based on a computer randomization plan. Two different food supplements, based on standardized cran

Sponsors

Indena Spa
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women 2. Age 18-40 years 3. BMI 18-25 kg/m2 4. Healthy

Exclusion criteria

Exclusion criteria: 1. Smokers 2. Allergy to cranberry 3. Gastrointestinal disorder 4. Liver and renal disease 5. Antibiotic treatment

Design outcomes

Primary

MeasureTime frame
Detection at time 1, 2, 4, 6, 10,12, 14, 24, 48 hours (from the intake of the last capsule) of cranberry bioactive constituents in urine (type A proanthocyanidin) and metabolites including hydroxybenzoic acids and valerolactones evaluated by high-resolution mass spectrometry.

Secondary

MeasureTime frame
1. Detection of other potential cranberry polyphenol metabolites in urines evaluated by high-resolution mass spectrometry 2. Ex-vivo inhibition of Candida albicans adhesion and biofilm formation by using the urine collected from the subjects at different time points

Countries

Italy

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026